Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125612511 | 12561251 | 1 | I | 20160706 | 20160715 | 20160715 | EXP | CA-PFIZER INC-2016344766 | PFIZER | 83.00 | YR | F | Y | 0.00000 | 20160715 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125612511 | 12561251 | 1 | PS | RAMIPRIL. | RAMIPRIL | 1 | Oral | 2.5 MG, 1X/DAY | 19901 | 2.5 | MG | QD | |||||||
125612511 | 12561251 | 2 | SS | HYDROCORTISONE. | HYDROCORTISONE | 1 | Unknown | UNK | 8697 | ||||||||||
125612511 | 12561251 | 3 | SS | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | Oral | 1250 MG, 1X/DAY | 0 | 1250 | MG | TABLET | QD | ||||||
125612511 | 12561251 | 4 | SS | BACLOFEN. | BACLOFEN | 1 | Oral | 20 MG, 3X/DAY | 0 | 20 | MG | TID | |||||||
125612511 | 12561251 | 5 | SS | CODEINE PHOSPHATE/PARACETAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | 1 DF, UNK | 0 | 1 | DF | TABLET | |||||||
125612511 | 12561251 | 6 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | TABLET | |||||||
125612511 | 12561251 | 7 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 4 DF, DAILY | 0 | 4 | DF | ||||||||
125612511 | 12561251 | 8 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 2 DF, 1X/DAY | 0 | 2 | DF | QD | |||||||
125612511 | 12561251 | 9 | SS | ASA | ASPIRIN | 1 | Unknown | 81 MG, 1X/DAY | 0 | 81 | MG | QD | |||||||
125612511 | 12561251 | 10 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, WEEKLY | 0 | 70 | MG | TABLET | /wk | ||||||
125612511 | 12561251 | 11 | SS | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 30 MG, 1X/DAY | 0 | 30 | MG | QD | |||||||
125612511 | 12561251 | 12 | SS | DARIFENACIN. | DARIFENACIN | 1 | Oral | 7.5 MG, UNK | 0 | 7.5 | MG | TABLET | |||||||
125612511 | 12561251 | 13 | SS | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Unknown | 1000 IU, 1X/DAY | 0 | 1000 | IU | QD | |||||||
125612511 | 12561251 | 14 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
125612511 | 12561251 | 15 | SS | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 0.88 MG, 1X/DAY | 0 | .88 | MG | QD | |||||||
125612511 | 12561251 | 16 | SS | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, UNK | 0 | 50 | MG | TABLET |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125612511 | 12561251 | OT |
125612511 | 12561251 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125612511 | 12561251 | Arteriosclerosis coronary artery | |
125612511 | 12561251 | Asphyxia | |
125612511 | 12561251 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |